Sealantium Medical announces completion of its phase I/II clinical study

Sealantium Medical has completed the enrolment of 32 patients to its randomized, open-label, comparator Phase I/II clinical study at four centers in the EU and the U.S. The study is evaluating the safety and efficacy of its flagship product, sFilm-FS, versus TachoSil, the market leading product, in controlling liver bleeding. Data from an interim analysis […]